Key result
Adolescent mitral valve prolapse is linked to higher sympathetic activity and shorter LVET vs controls.
Why the study?
Adolescents with mitral valve prolapse (MVP) often suffer from symptomatology that cannot be explained by mitral regurgitation alone, which may be linked to sympathetic autonomic dysfunction.
Is symptomatic primary mitral valve prolapse associated with enhanced sympathetic cardiovascular and autonomic regulation compared with healthy controls in adolescents?
Case-Control (n=96)
No
Is symptomatic primary mitral valve prolapse associated with enhanced sympathetic cardiovascular and autonomic regulation compared with healthy controls in adolescents?
Adolescents with symptomatic mitral valve prolapse exhibit enhanced resting cardiac and vascular sympathetic activity (higher 0V%, shorter LVET and RR interval, and higher blood pressure), suggesting non-invasive sympathetic indices may serve as early biomarkers of MVP-related autonomic dysfunction.
Answers are grounded in this paper and cite their sources.
May indicate autonomic involvement in adolescent MVP; hypothesis-generating and should not yet change practice.
Mitral valve prolapse (MVP) belongs to cardiac disorders characterized by impaired closure of mitral leaflets. We studied adolescent group of patients with MVP suffering from symptomatology that cannot be explained by mitral regurgitation alone. Several studies suggested that symptoms can be explained by autonomic, in particular sympathetic-linked dysfunction. Thus, we assessed non-invasive sympathetic indices of blood pressure and heart rate variability and electrodermal activity (EDA). Fifty-three adolescents with MVP (age: 15.1+/-0.4 years) and 43 healthy age- and gender-matched adolescents (age: 14.9+/-0.4 years) were examined. Blood pressure, heart rate and EDA were continuously recorded during 6-min rest. Evaluated parameters were: low frequency band of systolic blood pressure variability, systolic, diastolic and mean blood pressure, mean RR interval, cardiac sympathetic indices: symbolic dynamics (0V%), left ventricular ejection time (LVET), pre-ejection period (PEP), and EDA. Our findings revealed significantly higher systolic, diastolic, and mean blood pressure values, shortened mean RR interval, increased 0V%, and shortened LVET in MVP patients vs. controls (p=0.028, p<0.001, p=0.002, p<0.001, p=0.050, p<0.001; respectively). Our study revealed enhanced cardiovascular sympathetic regulation in adolescent MVP patients. We suggest that evaluation of non-invasive sympathetic parameters could represent potential biomarkers for early diagnosis of cardiovascular complications associated with MVP already at adolescent age.
No takes yet. Share an insight, caveat, or question.
Olexova et al. (2021) conducted a case-control in Adolescent mitral valve prolapse (MVP) (n=96). Symptomatic primary mitral valve prolapse (MVP) vs. Healthy age- and gender-matched controls was evaluated on Non-invasive sympathetic cardiovascular and autonomic indices (including symbolic dynamics 0V%, left ventricular ejection time [LVET], mean RR interval, and blood pressure) (p=0.050). Adolescents with mitral valve prolapse had higher cardiac sympathetic index 0V% (40.65 vs 33.72, p=0.050), shorter LVET (268.62 vs 289.49 ms, p<0.001), and higher blood pressure than controls.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: